Skip Navigation

A Phase I/II Study of Pembrolizumab MK-3475 in Children With Advanced Melanoma or a PD-L1 Positive Advanced, Relapsed or Refractory Solid Tumor or Lymphoma KEYNOTE-051

Brief Summary


Study Type:

I/II Identifier:

Study #:
CMH - ADVL1621

Start Date:
Nov 20, 2016

Full Details and Eligibility at

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below. ID: NCT02332668

View Complete Trial Details & Eligibility at